<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 1.6: Unmasking Autoimmunity: TPO and TgAb Testing | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 0 20px 80px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box h3 {
 color: #92400e;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
}

.welcome-box p {
 margin: 0;
 font-size: 16px;
 color: #44403c;
 line-height: 1.7;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #722F37;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #722F37;
 font-weight: 700;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 color: inherit;
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 border-left: 5px solid #722F37;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-icon {
 width: 48px;
 height: 48px;
 background: rgba(255, 255, 255, 0.2);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

.patient-profile {
 display: flex;
 align-items: center;
 gap: 16px;
 padding: 16px;
 background: #f9fafb;
 border-radius: 12px;
 margin-bottom: 20px;
}

/* DATA TABLE */
.data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
.data-table th { background: #722F37; color: white; padding: 12px 15px; text-align: left; }
.data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
.data-table tr:nth-child(even) { background: #f9fafb; }

/* COACH TIP */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* CHECK UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}
.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}
.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}
.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}
.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* TAKEAWAYS BOX */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}
.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}
.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}
.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES BOX */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box .box-label {
 color: #64748b;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 font-weight: 700;
 margin-bottom: 16px;
}

/* MODULE CONNECTION */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
}

.stat-highlight {
 color: #722F37;
 font-weight: 800;
}

@media (max-width: 768px) {
 .lesson-title { font-size: 28px; }
 .module-header-card { padding: 32px 24px; }
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 1: T: Testing & Tracking</span>
 <h1 class="lesson-title">Unmasking Autoimmunity: TPO and TgAb Testing</h1>
 <div class="lesson-meta">
 <span class="meta-badge">‚è±Ô∏è 15 min read</span>
 <span class="meta-badge">üìã Lesson 6 of 8</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Credential Verification</div>
 <div class="title">AccrediPro Standards Institute Verified Content</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <span class="toc-label">In This Lesson</span>
 <ul class="toc-list">
 <li><a href="#clinical-significance"><span class="section-num">01</span>Clinical Significance</a></li>
 <li><a href="#seronegative-mystery"><span class="section-num">02</span>The Seronegative Mystery</a></li>
 <li><a href="#flare-vs-remission"><span class="section-num">03</span>Flare vs. Remission Tracking</a></li>
 <li><a href="#titers-destruction"><span class="section-num">04</span>Antibody Titers & Tissue</a></li>
 <li><a href="#graves-markers"><span class="section-num">05</span>Graves' vs. Hashimoto's</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <p>In Lesson 1.5, we explored how the body converts T4 to T3 and the role of Reverse T3. However, even with perfect conversion, many clients still feel symptomatic. This is often because the <strong>underlying driver</strong> of the thyroid dysfunction‚Äîautoimmunity‚Äîhas not been addressed. Today, we look at the specific markers that reveal if the immune system is attacking the thyroid gland.</p>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>Welcome, Specialist</h3>
 <p>Did you know that in industrialized nations, <span class="highlight">up to 90% of hypothyroidism cases are actually Hashimoto's Thyroiditis</span>? Yet, most conventional doctors only test TSH. As a Thyroid Health Specialist, your ability to "unmask" autoimmunity through TPO and TgAb testing is what will set you apart and allow you to provide the life-changing results your clients are searching for.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Analyze the clinical roles of Thyroid Peroxidase (TPO) and Thyroglobulin (TgAb) antibodies.</li>
 <li>Identify the diagnostic criteria for "Seronegative Hashimoto's" and the necessity of ultrasound.</li>
 <li>Interpret antibody fluctuations as markers of immune system flares versus remission.</li>
 <li>Correlate antibody titers with the physical severity of thyroid tissue destruction.</li>
 <li>Distinguish between Hashimoto's and Graves' Disease using TSI and TRAb markers.</li>
 </ul>
 </div>

 <!-- Case Study -->
 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">üë©‚Äçüè´</div>
 <div>
 <p class="title">Case Study: The "Normal" Teacher</p>
 </div>
 </div>
 <div class="case-study-content">
 <div class="patient-profile">
 <div>
 <strong>Client:</strong> Sarah, 46, Elementary School Teacher<br>
 <strong>Presenting Symptoms:</strong> Brain fog, "crashing" at 3 PM, hair loss, and inability to lose weight despite a clean diet.<br>
 <strong>Conventional Labs:</strong> TSH: 2.8 uIU/mL (Standard Range), T4: 1.1 ng/dL (Standard Range).<br>
 <strong>Specialist Intervention:</strong> Sarah's specialist ran a full panel including TPO and TgAb. Her TPO was 450 IU/mL (optimal is < 15).<br>
 <strong>Outcome:</strong> Sarah was diagnosed with Hashimoto's. By identifying the autoimmune trigger (gluten sensitivity and chronic stress), her specialist helped her reduce antibodies to 80 IU/mL, restoring her energy for the classroom.
 </div>
 </div>
 </div>
 </div>

 <h2 id="clinical-significance">The Clinical Significance of TPO and TgAb</h2>
 <p>When we talk about thyroid autoimmunity, we are primarily looking at two "red flags" in the blood. These are not thyroid hormones; they are immune system proteins (antibodies) that have mistakenly identified thyroid tissue as a foreign invader.</p>

 <h3>1. Thyroid Peroxidase (TPO) Antibodies</h3>
 <p>TPO is an enzyme normally found in the thyroid gland that plays a crucial role in the production of thyroid hormones. It helps "link" iodine to thyroglobulin. When <span class="highlight">TPO antibodies</span> are present, the immune system is attacking this enzyme, effectively sabotaging the factory's machinery. TPO antibodies are the most common marker for Hashimoto's.</p>

 <h3>2. Thyroglobulin (TgAb) Antibodies</h3>
 <p>Thyroglobulin is the "storage protein" where thyroid hormones are kept before being released into the bloodstream. If TPO is the machinery, Thyroglobulin is the warehouse. <span class="highlight">TgAb antibodies</span> indicate an attack on the storage system. Interestingly, some clients may be negative for TPO but positive for TgAb, which still confirms Hashimoto's.</p>

 <div class="coach-tip">
 <span class="tip-label">Specialist Insight</span>
 <p>üí° <strong>Income Opportunity:</strong> Many of your clients will come to you with "normal" TSH tests from their GP. By offering a <strong>"Thyroid Mystery Deep Dive"</strong> ($350-$500 session), where you interpret these antibody markers that their doctor ignored, you provide immediate value and legitimacy. Sarah, the teacher in our case study, was happy to pay for this clarity after years of being told she was "just getting older."</p>
 </div>

 <h2 id="seronegative-mystery">Defining 'Seronegative Hashimoto's'</h2>
 <p>One of the biggest pitfalls for a practitioner is assuming that a negative antibody test means the client does <em>not</em> have Hashimoto's. This is a dangerous assumption.</p>
 
 <p>Statistics show that <span class="stat-highlight">approximately 10-15% of people with Hashimoto's are "seronegative,"</span> meaning their blood does not show elevated antibodies. This can happen because:</p>
 <ul>
 <li>The immune system is so exhausted it is no longer producing detectable levels of antibodies.</li>
 <li>The attack is currently "dormant" but tissue damage has already occurred.</li>
 <li>The antibodies are sequestered within the thyroid tissue itself and haven't spilled into the blood.</li>
 </ul>

 <p><strong>The Gold Standard for Confirmation:</strong> If a client has all the symptoms of Hashimoto's but negative blood markers, a <strong>Thyroid Ultrasound</strong> is necessary. An ultrasound can reveal a "heterogeneous" or "cobblestone" appearance of the gland, which is a physical signature of autoimmune damage, even in the absence of blood antibodies.</p>

 <h2 id="flare-vs-remission">Flare vs. Remission Tracking</h2>
 <p>As a specialist using the <strong>THRIVE Method‚Ñ¢</strong>, you must educate your clients that antibody numbers are not static. They are dynamic reflections of the immune system's current state of "alert."</p>

 <div class="alert-box info">
 <p class="alert-label">Tracking Philosophy</p>
 <p>We do not "chase the number to zero." While some clients achieve zero antibodies, many find a "functional baseline" where they feel great even with low-level antibodies (e.g., 30 IU/mL). We track <strong>trends</strong>, not single data points.</p>
 </div>

 <p><strong>What causes a "Flare" (Antibody Spike)?</strong></p>
 <ul>
 <li><strong>Gluten Exposure:</strong> Due to <em>molecular mimicry</em>, the immune system confuses gluten proteins with thyroid tissue.</li>
 <li><strong>Acute Stress:</strong> A death in the family or a high-stress project can trigger a surge in cortisol, which dysregulates the immune response.</li>
 <li><strong>Infection:</strong> Reactivation of viruses like Epstein-Barr (EBV) often correlates with TPO spikes.</li>
 </ul>

 <h2 id="titers-destruction">Antibody Titers and Tissue Destruction</h2>
 <p>A common question from clients is: <em>"Does a higher number mean my thyroid is being destroyed faster?"</em></p>
 
 <p>The answer is generally <strong>yes</strong>. Research indicates a correlation between the <strong>titer</strong> (the concentration of antibodies) and the degree of lymphocytic infiltration (the "attack") on the gland. However, it is not a 1:1 linear relationship. Some individuals with TPO antibodies in the 1000s have surprisingly functional glands, while others with titers of 150 experience rapid tissue failure.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Marker</th>
 <th>Optimal Functional Range</th>
 <th>Clinical Significance</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>TPO Ab</strong></td>
 <td>< 15 IU/mL</td>
 <td>Primary marker for Hashimoto's; indicates attack on hormone production.</td>
 </tr>
 <tr>
 <td><strong>TgAb</strong></td>
 <td>< 20 IU/mL</td>
 <td>Indicates attack on thyroid storage; often elevated when TPO is normal.</td>
 </tr>
 <tr>
 <td><strong>TSI</strong></td>
 <td>< 1.3 TSI index</td>
 <td>Primary marker for Graves' Disease (Hyperthyroidism).</td>
 </tr>
 </tbody>
 </table>

 <div class="coach-tip">
 <span class="tip-label">Communication Tip</span>
 <p>üí° When explaining high titers to a client, use the <strong>"Army Analogy."</strong> Tell them: "The antibodies are like soldiers. Right now, your body has 1,000 soldiers stationed at your thyroid. Our goal with the THRIVE Method‚Ñ¢ is to send those soldiers home on vacation so your thyroid can heal."</p>
 </div>

 <h2 id="graves-markers">Distinguishing Hashimoto's from Graves' (TSI/TRAb)</h2>
 <p>While Hashimoto's is the most common cause of hypothyroidism, we must also be aware of <strong>Graves' Disease</strong>, the autoimmune driver of hyperthyroidism. Sometimes, Hashimoto's clients can experience "Hashitoxicosis," where they temporarily feel hyperthyroid as the dying thyroid cells leak excess hormone into the blood.</p>

 <p>To distinguish between the two, we look at:</p>
 <ul>
 <li><strong>TSI (Thyroid Stimulating Immunoglobulin):</strong> This antibody mimics TSH and "turns on" the thyroid gland, causing it to overproduce hormone. This is the hallmark of Graves'.</li>
 <li><strong>TRAb (TSH Receptor Antibody):</strong> This can be either stimulating (Graves') or blocking (a rare form of Hashimoto's).</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Scope of Practice</span>
 <p>üí° As a specialist, you do not <em>diagnose</em> Graves' or Hashimoto's. You <strong>interpret the markers</strong> and <strong>collaborate</strong> with the client's physician. Your role is to provide the lifestyle and nutritional framework to lower these markers, while the doctor manages the medication.</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. A client presents with TPO antibodies of 12 (Optimal) but TgAb of 350. Does this client have Hashimoto's?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Yes. Hashimoto's can be confirmed by the elevation of <em>either</em> TPO or TgAb markers. The immune system may be targeting the storage protein (TgAb) rather than the enzyme (TPO).</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. What is the recommended next step for a client with strong hypothyroid symptoms but negative (seronegative) blood antibodies?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">A Thyroid Ultrasound. This can detect physical changes in the gland's texture (heterogeneity) that confirm autoimmunity even when blood markers are absent.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. True or False: The goal of the Thyroid Health Specialist is to always get antibodies to absolute zero.</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">False. While zero is great, the primary goal is symptom resolution and "functional remission." Many clients feel excellent and have no further tissue damage with stable, low-level antibodies.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. Which antibody marker is specific to Graves' Disease?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">TSI (Thyroid Stimulating Immunoglobulin). It mimics TSH and causes the overproduction of thyroid hormones.</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li><strong>90% Rule:</strong> Most hypothyroidism is autoimmune (Hashimoto's); testing TPO and TgAb is non-negotiable for a specialist.</li>
 <li><strong>TPO vs. TgAb:</strong> TPO attacks hormone production; TgAb attacks hormone storage. Both confirm autoimmunity.</li>
 <li><strong>Seronegativity:</strong> 10-15% of Hashimoto's cases won't show in blood; use ultrasound for these "mystery" cases.</li>
 <li><strong>Fluctuation:</strong> Antibodies reflect immune "flares" caused by gluten, stress, or infections.</li>
 <li><strong>TSI:</strong> Use TSI to differentiate Graves' Disease from Hashimoto's flares.</li>
 </ul>
 </div>

 <!-- References -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Pyzik, A. et al. (2015). "Immune disorders in Hashimoto's thyroiditis." <em>Journal of Immunology Research</em>.</li>
 <li>Zaletel, K. & Gaber≈°ƒçek, S. (2011). "Hashimoto's Thyroiditis: From Genes to the Disease." <em>Current Genomics</em>.</li>
 <li>Liontiris, M.I. et al. (2017). "A review of thyroid autoimmunity and the role of iodine and selenium." <em>Hellenic Journal of Nuclear Medicine</em>.</li>
 <li>Fr√∂hlich, E. & Wahl, R. (2017). "Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Clinical Practice." <em>Frontiers in Endocrinology</em>.</li>
 <li>McLeod, D.S. et al. (2014). "The Genetics of Thyroid Autoimmunity as a Window into Disease Pathogenesis." <em>Journal of Clinical Endocrinology & Metabolism</em>.</li>
 <li>Staii, A. et al. (2010). "Hashimoto's thyroiditis is more than just hypothyroidism." <em>Journal of Clinical Pathology</em>.</li>
 </ol>
 </div>
</div>

<script>
 document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 const isVisible = answer.style.display === 'block';
 answer.style.display = isVisible ? 'none' : 'block';
 this.textContent = isVisible ? 'Reveal Answer' : 'Hide Answer';
 }
 });
 });
</script>

</body>
</html>